McDavid Stilwell's Insider Trades & SAST Disclosures
McDavid Stilwell's most recent trade in Coherus Biosciences Inc was a trade of 18,440 Common Stock done at an average price of $3.3 . Disclosure was reported to the exchange on Dec. 31, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern McDavid Stilwell.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Coherus Biosciences Inc | McDavid Stilwell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.33 per share. | 31 Dec 2023 | 18,440 | 75,305 (0%) | 0% | 3.3 | 61,405 | Common Stock |
| Coherus Biosciences Inc | McDavid Stilwell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | McDavid Stilwell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.84 per share. | 01 Apr 2023 | 3,457 | 102,252 (0%) | 0% | 6.8 | 23,646 | Common Stock |
| Coherus Biosciences Inc | McDavid Stilwell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 40,000 | 104,243 (0%) | 0% | 0 | Common Stock | |
| Coherus Biosciences Inc | McDavid Stilwell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | McDavid Stilwell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.87 per share. | 04 Jan 2023 | 5,437 | 64,243 (0%) | 0% | 9.9 | 53,663 | Common Stock |
| Coherus Biosciences Inc | McDavid Stilwell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.85 per share. | 01 Apr 2022 | 3,458 | 69,680 (0%) | 0% | 12.8 | 44,435 | Common Stock |
| Coherus Biosciences Inc | McDavid Stilwell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | McDavid Stilwell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 40,000 | 73,138 (0%) | 0% | 0 | Common Stock | |
| Coherus Biosciences Inc | McDavid Stilwell | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 16.80 per share. | 15 Oct 2021 | 3,507 | 31,611 (0%) | 0% | 16.8 | 58,919 | Common Stock |
| Coherus Biosciences Inc | McDavid Stilwell | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 13.42 per share. | 09 Jun 2021 | 3,700 | 35,118 (0%) | 0% | 13.4 | 49,668 | Common Stock |
| Coherus Biosciences Inc | McDavid Stilwell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2021 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | McDavid Stilwell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2021 | 20,000 | 30,000 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges